Publications

We maintain this section to inform interested users about independent scientific studies conducted on MetaSystems products. We assume no responsibility or liability regarding the accuracy or correct use of the information or statements provided by external authors. The conclusions or statements expressed in the publications listed are those of the external authors or researchers. The publications may involve user-specific adaptations of MetaSystems products. They are not intended for diagnostic use. For publications covered by the Intended Purpose of Metafer or Ikaros, please refer to the respective instructions for use (IFU).

Filter by Keyword

Filter by Application

Filter by Product/Solution


Proc Natl Acad Sci U S A, 112(15), 4713–4718
April, 2015

Multiple mechanisms limit meiotic crossovers: TOP3alpha and two BLM homologs antagonize crossovers in parallel to FANCM.

Séguéla-Arnaud, Mathilde, Crismani, Wayne, Larchevêque, Cécile, Mazel, Julien, Froger, Nicole, Choinard, Sandrine, Lemhemdi, Afef, Macaisne, Nicolas, Van Leene, Jelle, Gevaert, Kris, De Jaeger, Geert, Chelysheva, Liudmilla, Mercier, Raphael

Meiotic crossovers (COs) have two important roles, shuffling genetic information and ensuring proper chromosome segregation. Despite their importance and a large excess of precursors (i.e., DNA double-strand breaks, DSBs), the number of COs is tightly regulated, typically one to three per chromosome pair. The mechanisms ensuring that most DSBs are repaired as non-COs and the evolutionary forces imposing this constraint are poorly understood. Here we identified Topoisomerase3α (TOP3α) and the RECQ4 helicases–the Arabidopsis slow growth suppressor 1 (Sgs1)/Bloom syndrome protein (BLM) homologs–as major barriers to meiotic CO formation. First, the characterization of a specific TOP3α mutant allele revealed that, in addition to its role in DNA repair, this topoisomerase antagonizes CO formation. Further, we found that RECQ4A and RECQ4B constitute the strongest meiotic anti-CO activity identified to date, their concomitant depletion leading to a sixfold increase in CO frequency. In both top3α and recq4ab mutants, DSB number is unaffected, and extra COs arise from a normally minor pathway. Finally, both TOP3α and RECQ4A/B act independently of the previously identified anti-CO Fanconi anemia of complementation group M (FANCM) helicase. This finding shows that several parallel pathways actively limit CO formation and suggests that the RECQA/B and FANCM helicases prevent COs by processing different substrates. Despite a ninefold increase in CO frequency, chromosome segregation was unaffected. This finding supports the idea that CO number is restricted not because of mechanical constraints but likely because of the long-term costs of recombination. Furthermore, this work demonstrates how manipulating a few genes holds great promise for increasing recombination frequency in plant-breeding programs.

Digital object identifier (DOI): 10.1073/pnas.1423107112

Stroke, 46(3), 835–842
March, 2015

Imaging of a clinically relevant stroke model: glucose hypermetabolismrevisited.

Fabian Arnberg, Jonas Grafstroem, Johan Lundberg, Sahar Nikkhou-Aski, Philip Little, Peter Damberg, Nicholas Mitsios, Jan Mulder, Li Lu, Michael Soederman, Sharon Stone-Elander, Staffan Holmin

Ischemic stroke has been shown to cause hypermetabolism of glucose in the ischemic penumbra. Experimental and clinical data indicate that infarct-related systemic hyperglycemia is a potential therapeutic target in acute stroke. However, clinical studies aiming for glucose control in acute stroke have neither improved functional outcome nor reduced mortality. Thus, further studies on glucose metabolism in the ischemic brain are warranted.We used a rat model of stroke that preserves collateral flow. The animals were analyzed by [2-(18)F]-2-fluoro-2-deoxy-d-glucose positron emission tomography or magnetic resonance imaging during 90-minute occlusion of the middle cerebral artery and during 60 minutes after reperfusion. Results were correlated to magnetic resonance imaging of cerebral blood flow, diffusion of water, lactate formation, and histological data on cell death and blood-brain barrier breakdown.We detected an increased [2-(18)F]-2-fluoro-2-deoxy-d-glucose uptake within ischemic regions succumbing to infarction and in the peri-infarct region. Magnetic resonance imaging revealed impairment of blood flow to ischemic levels in the infarct and a reduction of cerebral blood flow in the peri-infarct region. Magnetic resonance spectroscopy revealed lactate in the ischemic region and absence of lactate in the peri-infarct region. Immunohistochemical analyses revealed apoptosis and blood-brain barrier breakdown within the infarct.The increased uptake of [2-(18)F]-2-fluoro-2-deoxy-d-glucose in cerebral ischemia most likely reflects hypermetabolism of glucose meeting increased energy needs of ischemic and hypoperfused brain tissue, and it occurs under both anaerobic and aerobic conditions measured by local lactate production. Infarct-related systemic hyperglycemia could serve to facilitate glucose supply to the ischemic brain. Glycemic control by insulin treatment could negatively influence this mechanism.

Acta Neuropathol
February, 2015

Critical role of somatostatin receptor 2 in the vulnerability ofthe central noradrenergic system: new aspects on Alzheimer's disease.

Csaba Adori, Laura Glueck, Swapnali Barde, Takashi Yoshitake, Gabor G. Kovacs, Jan Mulder, Zsofia Magloczky, Laszlo Havas, Kata Boelcskei, Nicholas Mitsios, Mathias Uhlen, Janos Szolcsanyi, Jan Kehr, Annica Roennbaeck, Thue Schwartz, Jens F. Rehfeld, Tibor Harkany, Miklos Palkovits, Stefan Schulz, Tomas Hoekfelt

Alzheimer's disease and other age-related neurodegenerative disorders are associated with deterioration of the noradrenergic locus coeruleus (LC), a probable trigger for mood and memory dysfunction. LC noradrenergic neurons exhibit particularly high levels of somatostatin binding sites. This is noteworthy since cortical and hypothalamic somatostatin content is reduced in neurodegenerative pathologies. Yet a possible role of a somatostatin signal deficit in the maintenance of noradrenergic projections remains unknown. Here, we deployed tissue microarrays, immunohistochemistry, quantitative morphometry and mRNA profiling in a cohort of Alzheimer's and age-matched control brains in combination with genetic models of somatostatin receptor deficiency to establish causality between defunct somatostatin signalling and noradrenergic neurodegeneration. In Alzheimer's disease, we found significantly reduced somatostatin protein expression in the temporal cortex, with aberrant clustering and bulging of tyrosine hydroxylase-immunoreactive afferents. As such, somatostatin receptor 2 (SSTR2) mRNA was highly expressed in the human LC, with its levels significantly decreasing from Braak stages III/IV and onwards, i.e., a process preceding advanced Alzheimer's pathology. The loss of SSTR2 transcripts in the LC neurons appeared selective, since tyrosine hydroxylase, dopamine â-hydroxylase, galanin or galanin receptor 3 mRNAs remained unchanged. We modeled these pathogenic changes in Sstr2 (-/-) mice and, unlike in Sstr1 (-/-) or Sstr4 (-/-) genotypes, they showed selective, global and progressive degeneration of their central noradrenergic projections. However, neuronal perikarya in the LC were found intact until late adulthood (

Brain Struct Funct
January, 2015

Acute neuroinflammation in a clinically relevant focal cortical ischemicstroke model in rat: longitudinal positron emission tomography andimmunofluorescent tracking.

Miklos Toth, Philip Little, Fabian Arnberg, Jenny Haeggkvist, Jan Mulder, Christer Halldin, Balazs Gulyas, Staffan Holmin

<p>Adequate estimation of neuroinflammatory processes following ischemic stroke is essential for better understanding of disease mechanisms, and for the development of treatment strategies. With the TSPO (18 kDa translocator protein) positron emission tomography (PET) radioligand [<sup>11</sup>C]PBR28, we monitored longitudinally the inflammatory response post-transient cerebral ischemia in rats, using a recently developed rat stroke model that produces isolated focal cortical infarcts with clinical relevance in size and pathophysiology. Six Sprague-Dawley rats were subjected to 90 min transient endovascular occlusion of the M2 segment of the middle cerebral artery (M2CAO). Animals were imaged with a nanoScan® PET/MRI system at 1, 4, 7 and 14 days after M2CAO with a bolus injection of [<sup>11</sup>C]PBR28. In the infarct region, we found a significantly increased uptake of [<sup>11</sup>C]PBR28 on day 4, 7 and 14 compared to day 1 as well as compared to the contralateral cortex. No significant increase was detected in the contralateral cortex during the 14 days of imaging. The activation in the infarct region gradually decreased between day 4 and day 14. In an additional group of animals (<em>n</em> = 26), immunofluorescence studies were performed with antibodies for activated microglia/monocytes (Cd11b), phagocytes (Cd68), astrocytes (glial fibrillary acidic protein) and TSPO. The TSPO immunofluorescence signal indicated reactive microgliosis post injury, corresponding to PET findings. The present clinically relevant animal model and TSPO PET ligand appear to be well suited for studies on neuroinflammation after ischemic stroke.</p>

3 Biotech, 4, 635–645
December, 2014

Establishing cytogenetic biodosimetry laboratory in Saudi Arabia and producing preliminary calibration curve of dicentric chromosomes as biomarker for medical dose estimation in response to radiation emergencies.

Al-Hadyan, Khaled, Elewisy, Sara, Moftah, Belal, Shoukri, Mohamed, Alzahrany, Awad, Alsbeih, Ghazi

<p>In cases of public or occupational radiation overexposure and eventual radiological accidents, it is important to provide dose assessment, medical triage, diagnoses and treatment to victims. Cytogenetic bio-dosimetry based on scoring of dicentric chromosomal aberrations assay (DCA) is the "gold standard" biotechnology technique for estimating medically relevant radiation doses. Under the auspices of the National Science, Technology and Innovation Plan in Saudi Arabia, we have set up a biodosimetry laboratory and produced a national standard dose-response calibration curve for DCA, pre-required to estimate the doses received. For this, the basic cytogenetic DCA technique needed to be established. Peripheral blood lymphocytes were collected from four healthy volunteers and irradiated with radiation doses between 0 and 5 Gy of 320 keV X-rays. Then, lymphocytes were PHA stimulated, Colcemid division arrested and stained cytogenetic slides were prepared. The Metafer4 system (MetaSystems) was used for automatic and manually assisted metaphase finding and scoring of dicentric chromosomes. Results were fit to the linear-quadratic dose-effect model according to the IAEA EPR-Biodosimetry-2011 report. The resulting manually assisted dose-response calibration curve ( <em>(Y</em> = 0.0017 + 0.026 × <em>D</em> + 0.081 × <em>D</em><sup>2</sup>) was in the range of those described in other populations. Although the automated scoring over-and-under estimates DCA at low (&lt;1 Gy) and high (&gt;2 Gy) doses, respectively, it showed potential for use in triage mode to segregate between victims with potential risk to develop acute radiotoxicity syndromes. In conclusion, we have successfully established the first biodosimetry laboratory in the region and have produced a preliminary national dose-response calibration curve. The laboratory can now contribute to the national preparedness plan in response to eventual radiation emergencies in addition to providing information for decision makers and public health officials who assess the magnitude of public, medical, occupational and accidental radiation exposures.</p>

Digital object identifier (DOI): 10.1007/s13205-014-0217-x

Prenat Diagn, 34(11), 1066–1072
November, 2014

A new marker set that identifies fetal cells in maternal circulationwith high specificity.

Lotte Hatt, Marie Brinch, Ripudaman Singh, Kristine M\oller, Rune Hoff Lauridsen, Jacob M\orup Schlütter, Niels Uldbjerg, Britta Christensen, Steen K\olvraa

<p>Fetal cells from the maternal circulation (FCMBs) have the potential to replace cells from amniotic fluid or chorionic villi in a diagnosis of common chromosomal aneuploidies. Good markers for enrichment and identification are lacking.Blood samples from 78 normal pregnancies were used for testing the marker-set CD105 and CD141 for fetal cell enrichment. Fetal cell candidates were subsequently stained by a cocktail of cytokeratin antibodies, and the gender of the fetal cells was explored by fluorescence in situ hybridization (FISH) of the X and Y chromosomes.Fetal cell candidates could be detected in 91 % of the samples, and in 85 % of the samples, it was possible to obtain X and Y chromosomal FISH results for gender determination. The concordance between gender determined by FISH on fetal cells in maternal blood and gender found at birth reached 100 % if three or more fetal cells with FISH signals could be found in a sample.The marker set identifies fetal cells with specificity high enough to make cell-based noninvasive prenatal diagnosis realistic.</p>

Toxicol Sci, 140(1), 103–117
July, 2014

The gamma-H2AX Assay for Genotoxic and Nongenotoxic Agents: Comparisonof H2AX Phosphorylation with Cell Death Response.

Teodora Nikolova, Mirek Dvorak, Fabian Jung, Isabell Adam, Elisabeth Krämer, Aslihan Gerhold-Ay, Bernd Kaina

<p>DNA double-strand breaks (DSBs) and blocked replication forks resulting from bulky adducts and inhibitors of replication activate the DNA damage response (DDR), a signaling pathway marked by phosphorylation of histone 2AX (H2AX). The phosphorylated form, gamma-H2AX, accumulates at the site of the damage and can be visualized as foci by immunocytochemistry. The objective of this study was to assess if gamma-H2AX is a reliable biomarker for genotoxic exposures. To this end, we selected 14 well-known genotoxic compounds and compared them with 10 nongenotoxic chemicals, using CHO-9 cells because they are well characterized as to DNA repair and DDR. We quantified gamma-H2AX foci manually and automatically. In addition, total gamma-H2AX activation was determined by flow cytometry. For all chemicals the cytotoxic dose response was assayed by a metabolic cytotoxicity assay. We show that (1) all genotoxic agents induced γH2AX dose-dependently whereas nongenotoxic agents do not; (2) gamma-H2AX was observed for genotoxicants in the cytotoxic dose range, revealing a correlation between cytotoxicity and gamma-H2AX for genotoxic agents; for nongenotoxic agents cytotoxicity was not related to gamma-H2AX; (3) manual scoring of gamma-H2AX and automated scoring provided comparable results, the automated scoring was faster and investigator independent; (4) data obtained by foci counting and flow cytometry showed a high correlation, suggesting that gamma-H2AX scoring by flow cytometry has the potential for high-throughput analysis. However, the microscopic evaluation can provide additional information as to foci size, distribution, colocalization and background staining; (5) gamma-H2AX foci were colocalized with 53BP1 and Rad51, supporting the notion that they represent true DSBs. Collectively, the automated analysis of gamma-H2AX foci allows for rapid determination of genetic damage in mammalian cells. The data revealed that the induction of gamma-H2AX by genotoxicants is related to loss of viability and support gamma-H2AX as a reliable bio-indicator for pretoxic DNA damage.</p>

Mutagenesis, 29(3), 165–175
May, 2014

Automation and validation of micronucleus detection in the 3D EpiDerm™human reconstructed skin assay and correlation with 2D dose responses.

K. E. Chapman, A. D. Thomas, J. W. Wills, S. Pfuhler, S. H. Doak, G J S. Jenkins

<p>Recent restrictions on the testing of cosmetic ingredients in animals have resulted in the need to test the genotoxic potential of chemicals exclusively in vitro prior to licensing. However, as current in vitro tests produce some misleading positive results, sole reliance on such tests could prevent some chemicals with safe or beneficial exposure levels from being marketed. The 3D human reconstructed skin micronucleus (RSMN) assay is a promising new in vitro approach designed to assess genotoxicity of dermally applied compounds. The assay utilises a highly differentiated in vitro model of the human epidermis. For the first time, we have applied automated micronucleus detection to this assay using MetaSystems Metafer Slide Scanning Platform (Metafer), demonstrating concordance with manual scoring. The RSMN assay's fixation protocol was found to be compatible with the Metafer, providing a considerably shorter alternative to the recommended Metafer protocol. Lowest observed genotoxic effect levels (LOGELs) were observed for mitomycin-C at 4.8 µg/ml and methyl methanesulfonate (MMS) at 1750 µg/ml when applied topically to the skin surface. In-medium dosing with MMS produced a LOGEL of 20 µg/ml, which was very similar to the topical LOGEL when considering the total mass of MMS added. Comparisons between 3D medium and 2D LOGELs resulted in a 7-fold difference in total mass of MMS applied to each system, suggesting a protective function of the 3D microarchitecture. Interestingly, hydrogen peroxide (H2O2), a positive clastogen in 2D systems, tested negative in this assay. A non-genotoxic carcinogen, methyl carbamate, produced negative results, as expected. We also demonstrated expression of the DNA repair protein N-methylpurine-DNA glycosylase in EpiDerm™. Our preliminary validation here demonstrates that the RSMN assay may be a valuable follow-up to the current in vitro test battery, and together with its automation, could contribute to minimising unnecessary in vivo tests by reducing in vitro misleading positives.</p>

J Radiat Res
April, 2014

Biodosimetry estimation using the ratio of the longest:shortest lengthin the premature chromosome condensation (PCC) method applying autocaptureand automatic image analysis.

Jorge E. González, Ivonne Romero, Eric Gregoire, Cécile Martin, Ana I. Lamadrid, Philippe Voisin, Joan-Francesc Barquinero, Omar García

The combination of automatic image acquisition and automatic image analysis of premature chromosome condensation (PCC) spreads was tested as a rapid biodosimeter protocol. Human peripheral lymphocytes were irradiated with (60)Co gamma rays in a single dose of between 1 and 20 Gy, stimulated with phytohaemaglutinin and incubated for 48 h, division blocked with Colcemid, and PCC-induced by Calyculin A. Images of chromosome spreads were captured and analysed automatically by combining the Metafer 4 and CellProfiler platforms. Automatic measurement of chromosome lengths allows the calculation of the length ratio (LR) of the longest and the shortest piece that can be used for dose estimation since this ratio is correlated with ionizing radiation dose. The LR of the longest and the shortest chromosome pieces showed the best goodness-of-fit to a linear model in the dose interval tested. The application of the automatic analysis increases the potential use of the PCC method for triage in the event of massive radiation causalities.

Int J Radiat Biol, 90(4), 318–324
April, 2014

Effect of hypothermia on radiation-induced micronuclei and delayof cell cycle progression in TK6 cells.

Halina Lisowska, Karl Brehwens, Friedo Zölzer, Aneta Wegierek-Ciuk, Joanna Czub, Anna Lankoff, Siamak Haghdoost, Andrzej Wojcik

<p>Low temperature (hypothermia) during irradiation leads to a reduced frequency of micronuclei in TK6 cells and it has been suggested that perturbation of cell cycle progression is responsible for this effect. The aim of the study was to test this hypothesis.Human lymphoblastoid TK6 cells were treated by a combination of hypothermia (0.8°C) and ionizing radiation in varying order (hypothermia before, during or after irradiation) and micronuclei were scored. Growth assay and two-dimensional flow cytometry was used to analyze cell cycle kinetics following irradiated of cells at 0.8°C or 37.0°C.The temperature effect was observed at the level of micronuclei regardless of whether cells were cooled during or immediately before or after the radiation exposure. No indication of cell cycle perturbation by combined exposure to hypothermia and radiation could be detected.The protective effect of hypothermia observed at the level of cytogenetic damage was not due to a modulation of cell cycle progression. A possible alternative mechanism and experiments to test it are discussed.</p>

Environ Mol Mutagen, 55(2), 114–121
March, 2014

Influence of experimental conditions on data variability in the liver comet assay.

M. Guérard, C. Marchand, U. Plappert-Helbig

<p>The in vivo comet assay has increasingly been used for regulatory genotoxicity testing in recent years. While it has been demonstrated that the experimental execution of the assay, for example, electrophoresis or scoring, can have a strong impact on the results; little is known on how initial steps, that is, from tissue sampling during necropsy up to slide preparation, can influence the comet assay results. Therefore, we investigated which of the multitude of steps in processing the liver for the comet assay are most critical. All together eight parameters were assessed by using liver samples of untreated animals. In addition, two of those parameters (temperature and storage time of liver before embedding into agarose) were further investigated in animals given a single oral dose of ethyl methanesulfonate at dose levels of 50, 100, and 200 mg/kg, 3 hr prior to necropsy. The results showed that sample cooling emerged as the predominant influence factor, whereas variations in other elements of the procedure (e.g., size of the liver piece sampled, time needed to process the liver tissue post-mortem, agarose temperature, or time of lysis) seem to be of little relevance. Storing of liver samples of up to 6 hr under cooled conditions did not cause an increase in tail intensity. In contrast, storing the tissue at room temperature, resulted in a considerable time-dependent increase in comet parameters. Environ. Mol. Mutagen. 55:114-121, 2014. © 2013 Wiley Periodicals, Inc.</p>

Int J Radiat Biol, 90(2), 193–202
February, 2014

Inter- and intra-laboratory comparison of a multibiodosimetric approach to triage in a simulated, large scale radiation emergency.

Elizabeth A. Ainsbury, Jenna Al-Hafidh, Ainars Bajinskis, Stephen Barnard, Joan Francesc Barquinero, Christina Beinke, Virginie de Gelder, Eric Gregoire, Alicja Jaworska, Carita Lindholm, David Lloyd, Jayne Moquet, Reetta Nylund, Ursula Oestreicher, Sandrine Roch-Lefévre, Kai Rothkamm, Horst Romm, Harry Scherthan, Sylwester Sommer, Hubert Thierens, Charlot Vandevoorde, Anne Vral, Andrzej Wojcik

<p>The European Union's Seventh Framework Programme-funded project 'Multi-disciplinary biodosimetric tools to manage high scale radiological casualties' (MULTIBIODOSE) has developed a multiparametric approach to radiation biodosimetry, with a particular emphasis on triage of large numbers of potentially exposed individuals following accidental exposures. In November 2012, an emergency exercise took place which tested the capabilities of the MULTIBIODOSE project partners. The exercise described here had a dual purpose: Intercomparison of (i) three biodosimetric assays, and (ii) the capabilities of the seven laboratories, with regards to provision of triage status for suspected radiation exposed individuals.Three biological dosimetry tools - the dicentric, micronucleus and gamma-H2AX (the phosphorylated form of member X of histone H2A, in response to DNA double-strand breaks) foci assays - were tested, in addition to provision of the triage status results (low exposure: 2 Gy) by the MULTIBIODOSE software. The exercise was run in two modes: An initial triage categorisation of samples (based on the first dose estimates for each assay received from each laboratory) followed by collation of the full set of estimated doses (all the results from all modes of each assay carried out by the participating laboratories) calculated using as many modes of operation as possible of the different assays developed during the project. Simulated acute whole body and partial body exposures were included.The results of the initial triage categorisation and the full comparison of assays and methods within and between laboratories are presented here.The data demonstrate that the MULTIBIODOSE approach of applying multiparametric tools to radiation emergencies is valid and effective.</p>

Prenat Diagn
February, 2014

Validation of automatic scanning of microscope slides in recoveringrare cellular events: application for detection of fetal cells inmaternal blood.

Ahmed Emad, Eric F. Bouchard, Jos?e Lamoureux, Annie Ouellet, Aparajita Dutta, Uli Klingbeil, Régen Drouin

<p>Detection of rare fetal cells (FCs) in the maternal circulation could be used for non-invasive prenatal diagnosis. Considering that FCs in maternal blood are present in extremely low frequency, manual scanning is cumbersome, time-consuming and unsuitable for clinical applications. As an alternative, we optimized a custom-made classifier for automatic detection of FCs.Using MetaSystems' automated platform, we developed a robust detection algorithm and validated its efficiency on retrieval of rare XY cells in a pure population of XX cells. Slides were scanned for presence of predefined XY cells after fluorescence in situ hybridization (FISH) and primed in situ labeling (PRINS). Retrieval of FCs was also performed on samples from maternal blood.The efficiency of detection of rare XY cells was 88 % using FISH (117/133) in comparison to 78 % (53/68) with PRINS. FC frequencies per 1 ml of maternal blood ranged from 3-6 FCs in normal pregnancies versus 13-21 FCs in Down syndrome pregnancies.Automatic scanning was more efficient and consistent than manual scanning for detection of rare FCs and required considerably less operator time. Automatic scanning using FISH is more sensitive than that using PRINS. The study validates automatic scanning retrieval of FCs from maternal blood. This article is protected by copyright. All rights reserved.</p>

Int J Radiat Biol, 90(2), 149–158
February, 2014

Induction and disappearance of gammaH2AX foci and formation of micronuclei after exposure of human lymphocytes to (60)Co gamma-rays and p(66)+ Be(40) neutrons.

Veerle Vandersickel, Philip Beukes, Bram Van Bockstaele, Julie Depuydt, Anne Vral, Jacobus Slabbert

<p>To investigate both the formation of micronuclei (MN) and the induction and subsequent loss of phosphorylated histone H2AX foci (gammaH2AX foci) after in vitro exposure of human lymphocytes to either (60)Co gamma-rays or p(66)+ Be(40) neutrons.MN dose response (DR) curves were obtained by exposing isolated lymphocytes of 10 different donors to doses ranging from 0-4 Gy gamma-rays or 0-2 Gy neutrons. Also, gammaH2AX foci DR curves were obtained following exposure to doses ranging from 0-0.5 Gy of either gamma-rays or neutrons. Foci kinetics for lymphocytes for a single donor exposed to 0.5 Gy gamma-rays or neutrons were studied up to 24 hours post-irradiation.Micronuclei yields following neutron exposure were consistently higher compared to that from (60)Co gamma-rays. All MN yields were over-dispersed compared to a Poisson distribution. Over-dispersion was higher after neutron irradiation for all doses &gt; 0.1 Gy. Up to 4 hours post-irradiation lower yields of neutron-induced gammaH2AX foci were observed. Between 4 and 24 hours the numbers of foci from neutrons were consistently higher than that from gamma-rays. The half-live of foci disappearance is only marginally longer for neutrons compared to that from gamma-rays. Foci formations were more likely to be over-dispersed for neutron irradiations.Although neutrons are more effective to induce MN, the absolute number of induced gammaH2AX foci are less at first compared to gamma-rays. With time neutron-induced foci are more persistent. These findings are helpful for using gammaH2AX foci in biodosimetry and to understand the repair of neutron-induced cellular damage.</p>

blood, 1850-1859
2014

Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphoma

Edith Chevret, Laetitia Andrique, Martina Prochazkova-Carlotti, Jacky Ferrer, David Cappellen, Elodie Laharanne, Yamina Idrissi, Anna Boettiger, Wafa Sahraoui, Florian Ruiz, Anne Pham-Ledard, Beatrice Vergier, Francis Belloc, Pierre Dubus, Marie Beylot-Barry, Jean-Philippe Merlio

Telomere erosion may be counteracted by telomerase. Here we explored telomere length (TL) and telomerase activity (TA) in primary cutaneous T-cell lymphoma (CTCL) by using quantitative polymerase chain reaction and interphase quantitative fluorescence in situ hybridization assays. Samples from patients with S´ezary syndrome (SS), transformed mycosis fungoides (T-MF), and cutaneous anaplastic large cell lymphoma were studied in parallel with corresponding cell lines to evaluate the relevance of TL and TA as target candidates for diagnostic and therapeutic purposes. Compared with controls, short telomeres were observed in aggressive CTCL subtypes such as SS and T-MF and were restricted to neoplastic cells in SS. While no genomic alteration of the hTERT (human telomerase catalytic subunit) locus was observed in patients’ tumor cells, TA was detected. To understand the role of telomerase in CTCL, we manipulated its expression in CTCL cell lines. Telomerase inhibition rapidly impeded in vitro cell proliferation and led to cell death, while telomerase overexpression stimulated in vitro proliferation and clonogenicity properties and favored tumor development in immunodeficient mice. Our data indicate that, besides maintenance of TL, telomerase exerts additional functions in CTCL. Therefore, targeting these functions might represent an attractive therapeutic strategy, especially in aggressive CTCL.

Modern Pathology, 402-411
2014

Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma

Anne Pham-Ledard, Martina Prochazkova-Carlotti, Laetitia Andrique, David Cappellen, Béatrice Vergier, Fabian Martinez, Florent Grange, Tony Petrella, Marie Beylot-Barry, Jean-Philippe Merlio

<p>Primary cutaneous large B-cell lymphoma, leg type has been individualized from nodal diffuse large B-cell lymphoma. The objective of this study was to screen primary cutaneous large B-cell lymphoma, leg type for genetic alterations recently described in nodal diffuse large B-cell lymphoma. Skin biopsies from 23 patients were analyzed for IRF4, BCL2, BCL6, and MYC expression. FISH testing was performed for BCL2, BCL6, MYC with separation probes and for CDKN2A and PRDM1/BLIMP1 deletion. Multiple sequential FISH analyses with up to six probes were performed to define samples with multiple cytogenetic alterations. MYD88 mutations were studied by Sanger sequencing. All cases but one displayed at least one genetic alteration (96%). Nine patients exhibited a single genetic mutation and 12 combined several alterations (52%). We observed a split for BCL2, BCL6, or MYC in 1/23, 6/23, and 3/23 of cases, respectively. No double-hit lymphoma was observed. CDKN2A deletion was detected by FISH in only 5/23 cases. BLIMP1 and/or 6q deletion was observed at a higher rate in 10/20 of cases. No correlation between rearrangement and immunohistochemical expression was found for BCL2 or MYC. FISH tracking of sequential hybridizations showed that several alterations were carried by the same nuclei. The p.L265P MYD88 mutation was found in 11/18 (61%) of cases. Contrary to most cutaneous lymphomas that rarely harbor primary genetic alteration of their nodal histological equivalent, primary cutaneous large B-cell lymphoma, leg type seems to be a 'cutaneous counterpart' of activated B-cell-like diffuse large B-cell lymphoma with a similar cytogenetic profile and a high rate of MYD88 oncogenic L265P mutation. This also suggests a common lymphomagenesis with NF-jB activation, strong IRF4 expression and terminal B-cell differentiation blockage. Our data support the use of therapies targeting NF-jB, as most patients displayed disease progression and resistance to conventional therapies.</p>

EJNMMI Res, 4(1), 17
2014

Visualization of angiogenesis during cancer development in the polyoma middle T breast cancer model: molecular imaging with (R)-[11C]PAQ.

Samén, Erik, Lu, Li, Mulder, Jan, Thorell, Jan-Olov, Damberg, Peter, Tegnebratt, Tetyana, Holmgren, Lars, Rundqvist, Helene, Stone-Elander, Sharon

Vascular endothelial growth factor receptor 2 (VEGFR2) is a crucial mediator of tumour angiogenesis. High expression levels of the receptor have been correlated to poor prognosis in cancer patients. Reliable imaging biomarkers for stratifying patients for anti-angiogenic therapy could therefore be valuable for increasing treatment success rates. The aim of this study was to investigate the pharmacokinetics and angiogenesis imaging abilities of the VEGFR2-targeting positron emission tomography (PET) tracer (R)-[11C]PAQ.(R)-[11C]PAQ was evaluated in the mouse mammary tumour virus-polyoma middle T (MMTV-PyMT) model of metastatic breast cancer. Mice at different stages of disease progression were imaged with (R)-[11C]PAQ PET, and results were compared to those obtained with [18 F]FDG PET and magnetic resonance imaging. (R)-[11C]PAQ uptake levels were also compared to ex vivo immunofluorescence analysis of tumour- and angiogenesis-specific biomarkers. Additional pharmacokinetic studies were performed in rat and mouse.A heterogeneous uptake of (R)-[11C]PAQ was observed in the tumorous mammary glands. Ex vivo analysis confirmed the co-localization of areas with high radioactivity uptake and areas with elevated levels of VEGFR2. In some animals, a high focal uptake was observed in the lungs. The lung uptake correlated to metastatic and angiogenic activity, but not to uptake of [18 F]FDG PET. The pharmacokinetic studies revealed a limited metabolism and excretion during the 1-h scan and a distribution of radioactivity mainly to the liver, kidneys and lungs. In rat, a high uptake was additionally observed in adrenal and parathyroid glands.The results indicate that (R)-[11C]PAQ is a promising imaging biomarker for visualization of angiogenesis, based on VEGFR2 expression, in primary tumours and during metastasis development.

Digital object identifier (DOI): 10.1186/2191-219X-4-17

Revista brasileira de ortopedia, 49, 62–68
2014

Effect of hyaluronic acids as chondroprotective in experimental model of osteoarthrosis.

Oliveira, Marcello Zaia, Albano, Mauro Batista, Namba, Mario Massatomo, da Cunha, Luiz Antônio Munhoz, de Lima Gonçalves, Renan Rodrigues, Trindade, Edvaldo Silva, Andrade, Lucas Ferrari, Vidigal, Leandro

<p>To analyze the effects of hyaluronic acid of different molecular weights in an experimental model of osteoarthritis in rabbits. forty-four male California rabbits were divided randomly into three groups and underwent resection of the anterior cruciate ligament in his right knee. After three weeks of the surgical procedure began three weekly intra-articular injections of hyaluronic acid native (Polireumin®)-PR, hyaluronic acid branched chain (Synvisc®)-S and 0.9% saline-P. All animals were sacrificed after twelve weeks of surgery and tibial plateau infiltrated the knees were dissected. Histological cartilage of the support areas of the tibial plateaus were stained with Alcian Blue pH 1.0, Alcian Blue pH = 2.5 and toluidine blue for research on the amount of proteoglycans. The intensity of staining was quantified on a Zeiss microscope apparatus Imager Z2 MetaSystems and analyzed by software MetaferMsearch. the effect of chondroprotetor hyaluronic acids used in the study was confirmed when compared to the control group, but the comparison made between them, there was no statistically significant difference regarding chondroprotetion. The hyaluronic acids tested had chondroprotective effect, with no statistical difference with regard to the different molecular weights.</p>

Digital object identifier (DOI): 10.1016/j.rboe.2014.01.007

Haematologica, 98(12), e166–e168
December, 2013

First description of the t(10;11)(q22;q23)/MLL-TET1 translocationin a T-cell lymphoblastic lymphoma, with subsequent lineage switchto acute myelomonocytic myeloid leukemia.

Antoine Ittel, Eric Jeandidier, Catherine Helias, Nathalie Perrusson, Catherine Humbrecht, Bruno Lioure, Isabelle Mazurier, Caroline Mayeur-Rousse, Amandine Lavaux, Sylvie Thiebault, Felix Lerintiu, Carine Gervais, Laurent Mauvieux

<p>In the April 2013 issue of Haematologica, Lee <em>et al.</em> have described the <em>TET1</em> genomic breakpoints and clinical features of <em>MLL-TET1</em> rearranged cases of acute leukemia. So far, 13 cases have been reported in the literature, 11 in acute myeloid leukemia (AML) patients and 2 in B-cell precursor acute lymphoblastic leukemia (ALL). It was also recently reported that <em>MLL</em> is fused to <em>TET1</em> in only 5 out of 1,590 <em>MLL</em> rearranged <em>AML</em> cases (0.3%). Although those cases are very uncommon, their study can improve our current understanding of leukemogenesis. We report here the first t(10;11) <em>MLL-TET1</em> positive case of T-cell lymphoblastic lymphoma occurring in a 31-year old male patient, with a subsequent transformation to AML.</p> <p>The patient was referred for a large mediastinal mass and right pleural effusion. Blood cell count showed no abnormalities. Mediastinal and bronchus biopsies led to the diagnosis of a precursor-T-cell lymphoblastic lymphoma (pre-T LBL), expressing CD3, CD5, CD4, CD8 and CD10 antigens, together with a high expression of Ki67 (90%). No expression of CD34 or CD79a was observed. The same cells were observed in pleural fluid that expressed CD3, CD4, CD8, CD2, CD7, CD10 antigens but neither CD34 nor myeloperoxidase. Bone marrow examination and central nervous system imaging did not show any other specific localization. The patient was treated following the Groupe d’Etudes des Lymphomes de l’Adulte (GELA) LL03 protocol, and was considered in complete remission after induction and consolidation phases. A 32×22×48 mm residual mediastinal mass remained after treatment, without hypermetabolic abnormality on the FDG-PET scan and was considered to be fibronecrotic scar tissue. Fourteen months after the diagnosis, during the maintenance therapy, a bone marrow examination was performed for thrombopenia (6 g/L) that revealed a myelomonocytic acute leukemia with trilineage dysplasia. The mediastinal mass remained unchanged on the imaging scan. The patient achieved complete remission after intensive chemotherapy based on cytarabine and daunorubicin, followed by a consolidation course with high-dose cytarabine. A non-familial donor allogeneic bone marrow transplant (10/10 match) was performed four months after the diagnosis of the acute myeloid leukemia that was complicated by a Grade IV acute graft-<em>versus</em>-host disease involving digestive tract, liver and skin. The patient died 54 days after the transplant of bacterial sepsis leading to multi-organ failure.</p>

J Dermatol Sci, 72(3), 304–310
December, 2013

A purified Feverfew extract protects from oxidative damage by inducing DNA repair in skin cells via a PI3-kinase-dependent Nrf2/ARE pathway.

Karien J. Rodriguez, Heng-Kuan Wong, Thierry Oddos, Michael Southall, Balz Frei, Simarna Kaur

Environmental factors such as solar ultraviolet (UV) radiation and other external aggressors provide an oxidative challenge that is detrimental to skin health. The levels of endogenous antioxidants decrease with age, thus resulting in less protection and a greater potential for skin damage. The NF-E2-related factor-2 (Nrf2) - antioxidant response element (ARE) pathway is a primary defense mechanism against oxidative stress, and induces the expression of antioxidant, detoxification and repair genes. Activation of ARE-Nrf2 can help restore oxidative homeostasis of the skin and play a role in inflammatory response and DNA repair mechanisms.To evaluate the role of a purified parthenolide-depleted Feverfew (PD-Feverfew) extract on the ARE-Nrf2 pathway and DNA repair in skin cells.These studies were undertaken in primary human keratinocytes or KB cells using Luciferase Promoter assay, siRNA transfection studies, Western blot analyses, Immunofluorescence microscopy, comet assay and quantitative real-time PCR.PD-Feverfew was found to induce Nrf2 nuclear translocation and to increase ARE activity in a dose dependent manner. Furthermore, knockdown of Nrf2 resulted in suppression of PD-Feverfew-induced ARE activity. PD-Feverfew was also found to induce phosphorylation of Akt, a kinase downstream of PI3K. Inhibition of PI3K via pre-treatment with the selective pharmacological inhibitor, LY294002, abolished PD-Feverfew-induced Nrf2/ARE activation. PD-Feverfew also reduced UV-induced DNA damage in a PI3K and Nrf2-dependent manner.Therefore, by increasing endogenous defense mechanisms and aid in DNA repair of damaged skin cells via activation of a PI3K-dependent Nrf2/ARE pathway, PD-Feverfew may help protect the skin from numerous environmental aggressors.

Digital object identifier (DOI): 10.1016/j.jdermsci.2013.08.004